Bank of New York Mellon Corp
BankPosition in TARA — Protara Therapeutics, Inc.
CIK 1390777
NEW YORK, NY
Position in TARA
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$525,969
-$149,616 QoQ
Shares Held
137,689
+6.2% QoQ
Ownership
0.233%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 118 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 86%
Shared 0%
None 14%
Common Shares in TARA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. TARA ranks #239 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in TARA
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $525,969 | 137,689 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $675,585 | 129,671 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $498,471 | 93,522 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $421,918 | 96,993 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $285,173 | 94,117 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $78,169 | 18,350 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $83,861 | 15,883 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $32,769 | 17,907 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $37,246 | 17,907 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $71,806 | 17,907 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $33,575 | 17,907 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $29,904 | 17,907 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $42,797 | 17,907 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $56,048 | 17,907 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $47,990 | 17,907 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $53,003 | 17,907 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $52,467 | 17,907 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $91,503 | 17,907 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $120,872 | 17,907 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $123,915 | 17,907 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $174,413 | 17,907 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $404,281 | 25,685 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $608,687 | 25,142 | Shares | Defined | 2021-02-09 | |
| No filing history on record for this holder in this stock. | ||||||